About SynThera Biomedical
SynThera Biomedical is a company based in Pune (India) founded in 2015 by Nilay Lakhkar. SynThera Biomedical has raised $406.24 thousand across 2 funding rounds from investors including Italica, 1Crowd and United Capital PLC Group. SynThera Biomedical offers products and services including Porosyn, Therasenz, Bioactive Glass Powder, and Frit and Cullet. SynThera Biomedical operates in a competitive market with competitors including MiMedx Group, Ossio, Theradaptive, EpiBone and Biocomposites, among others.
- Headquarter Pune, India
- Founders Nilay Lakhkar
- Stage Minicorn
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Synthera Biomedical Private Limited
- Date of Incorporation 19 Jun, 2015
- Jurisdiction Pune, Maharashtra, India
-
Annual Revenue
$48.83 K (USD)369.59as on Mar 31, 2022
-
Net Profit
$2.78 K (USD)134.38as on Mar 31, 2022
-
EBITDA
-$38.15 K (USD)-122.3as on Mar 31, 2022
-
Total Equity Funding
$406.24 K (USD)
in 2 rounds
-
Latest Funding Round
$101.24 K (USD), Seed
Nov 10, 2021
-
Investors
Italica
& 32 more
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of SynThera Biomedical
SynThera Biomedical offers a comprehensive portfolio of products and services, including Porosyn, Therasenz, Bioactive Glass Powder, and Frit and Cullet.
Optimizes tissue repair and bone regeneration for medical use
Facilitates healing in dental and fracture repair applications
Provides customized powders for pharmaceutical and cosmetic needs
Offers high-purity materials for industrial and medical processing
Funding Insights of SynThera Biomedical
SynThera Biomedical has successfully raised a total of $406.24K across 2 strategic funding rounds. The most recent funding activity was a Seed round of $101.24 thousand completed in November 2021. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in SynThera Biomedical
SynThera Biomedical has secured backing from 33 investors, including venture fund, institutional, and angel investors. Prominent investors backing the company include Italica, 1Crowd and United Capital PLC Group.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Med-tech startups are incubated by IKP Knowledge Park.
|
Locked | Locked | Locked | |
|
Business incubation services are provided across multiple sectors.
|
Locked | Locked | Locked | |
|
Startups are incubated at Venture Center, backed by CSIR.
|
Locked | Locked | Locked |
Investor details for SynThera Biomedical
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by SynThera Biomedical
Investment portfolio details for SynThera Biomedical
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - SynThera Biomedical
Detailed financials for SynThera Biomedical
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Synthera Biomedical Comparisons
Peer comparison for SynThera Biomedical
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of SynThera Biomedical
SynThera Biomedical operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as MiMedx Group, Ossio, Theradaptive, EpiBone and Biocomposites, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Regenerative biomaterial products and bioimplants for wound, surgical, sports medicine and orthopedics
|
|
| Locked | Locked | Locked |
Orthopedic fixation is enabled by bone regeneration biocomposite technology.
|
|
| Locked | Locked | Locked |
Therapeutic delivery platform is developed for orthopedic clinical indications.
|
|
| Locked | Locked | Locked |
Developer of stem cells to regrow damaged bones
|
|
| Locked | Locked | Locked |
Synthetic calcium composites are developed for bone repair and regeneration.
|
|
| Locked | Locked | Locked |
Implants for bone and cartilage regeneration are developed and provided.
|
Detailed competitors of SynThera Biomedical
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Synthera Biomedical
Complete news archive for SynThera Biomedical
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about SynThera Biomedical
SynThera Biomedical was founded in 2015 and raised its 1st funding round 3 years after it was founded.
SynThera Biomedical is headquartered in Pune, India. It is registered at Pune, Maharashtra, India.
Nilay Lakhkar is the current CEO of SynThera Biomedical. They have also founded this company.
SynThera Biomedical is a funded company, having raised a total of $406.24K across 2 funding rounds to date.
Annual revenue of SynThera Biomedical is $48.83K as on Mar 31, 2022.
SynThera Biomedical was established in 2015 in Pune, India. Bio-active glass and ceramic products are developed, manufactured, and commercialized for healthcare and related sectors. Silicate- or phosphate-based materials are applied in dental, maxillofacial, and orthopedic bone substitutes, tissue engineering scaffolds, and antimicrobial ion delivery systems. Operations focus on specialty biomaterials for various biomedical uses.
SynThera Biomedical's top competitors include EpiBone, Theradaptive and MiMedx Group.
SynThera Biomedical offers Porosyn, Therasenz, Bioactive Glass Powder, and Frit and Cullet.
SynThera Biomedical has 33 investors. Key investors include Italica, 1Crowd, United Capital PLC Group, IKP Knowledge Park, and United Capital Club.
The valuation of SynThera Biomedical is $1.36M as of Apr 2018.